Total raised
$249.7M
Last: PIPE 2025-01
Stage
Public
Founded
2001
Headcount
23
HQ
Yokne'am Illit
Sector
Health Tech & Life Sciences
About
Lifeward mission is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. The company is committed to delivering groundbreaking solutions that empower individuals to do what they love.
As a global market leader in pioneering life-changing solutions, its portfolio features innovative products including the ReWalk Exoskeleton, the ReStore Exo-Suit, the MYOLYN FES bikes, and its newest addition, the AlterG Anti-Gravity systems.
Funding history · 14 rounds · $249.7M total
2025-01
PIPE
$5.0M
2021-09
PIPE
$32.5M
2021-02
PIPE
$40.0M
2020-12
PIPE
$8.0M
2020-07
PIPE
$9.0M
2019-06
PIPE
$5.0M
2019-04
PIPE
$4.3M
2018-03
PIPE
$20.0M
2016-01
Convertible Bond
$20.0M
2014-07
Series E
$17.0M
2013-06
Series D
$1.2M
2011-07
Series C
$7.0M
2009-11
Undisclosed
$3.1M
2007-01
Undisclosed
Undisclosed
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- When did Lifeward, formerly ReWalk Robotics, go public on NASDAQ?
- Lifeward, under its former name ReWalk Robotics, went public on NASDAQ in September 2014.
- What significant acquisition did ReWalk Robotics complete in August 2023?
- In August 2023, ReWalk Robotics completed the acquisition of AlterG for $19 million, aiming to build commercial scale and accelerate its path to profitability.
- What was a key development for ReWalk Robotics' ReBoot Soft Exo-Suit in November 2021?
- In November 2021, the FDA designated ReWalk's ReBoot Soft Exo-Suit as a Breakthrough Device.
- What was a notable achievement for ReWalk Robotics in March 2022?
- In March 2022, a ReWalker set a Guinness World Record for climbing a London skyscraper while wearing an exoskeleton, showcasing the ReWalk technology.
- What was the total amount raised by Lifeward (formerly ReWalk Robotics) through all funding rounds?
- Lifeward has raised a total of $249.72 million across all its funding rounds. For a full financing history, please refer to startupim.
- What was a significant policy change regarding ReWalk's personal exoskeleton in February 2019?
- In February 2019, Cigna became the first private U.S. insurer to adopt a national policy change for coverage of personal exoskeleton devices, including ReWalk's.
- What was the latest funding round for Lifeward, and when did it occur?
- The latest funding round for Lifeward was a PIPE round in January 2025, raising $5 million.
- What was a major development for ReWalk Robotics in October 2020 regarding Medicare?
- In October 2020, ReWalk Robotics received Medicare Provider Certification, which was a significant step for insurance coverage.
- What was the company's market capitalization as of November 2023?
- As of November 1, 2023, Lifeward's market capitalization was $44,886,820.
- What was a key regulatory approval for ReWalk's technology in March 2023?
- In March 2023, ReWalk technology achieved FDA clearance as the only personal exoskeleton to enable use on stairs and curbs.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Accessibility SolutionsMedical DevicesAssistive Devices
Technologies
CommunicationsIOTMachinery & RoboticsExoskeletonSensing
Target customers
Healthcare & Life SciencesHealthcareProvidersPatients
Business model
B2BB2C
Highlights
1 Patents
Tags
wearabledisabilitiesmedical-devicesiotorthopedicsrehabilitationsensorsassistive-devicesphysiotherapystroketelehealthroboticsdigital-healthcarereal-timewearable